IGC PHARMA, INC. Inventory
IGC PHARMA, INC. (IGC) had Inventory of $640.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Assets › Assets, Current › Inventory, Net
us-gaap:InventoryNet · last filed 2026-08-14
- 2026-06-30: Inventory, Net $640.00K.
- 2026-03-31: Inventory, Net $638.00K.
- 2025-12-31: Inventory, Net $640.00K.
- 2025-09-30: Inventory, Net $658.00K.
| Period end | Inventory, Net | Inventory, Net as first filed |
|---|---|---|
| 2026-06-30 | $640.00K 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $638.00K 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $640.00K 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $658.00K 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $1.35M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $1.36M 10-KT · filed 2026-03-18 | |
| 2024-12-31 | $1.43M 10-Q · filed 2025-02-14 | |
| 2024-09-30 | $1.51M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $1.51M 10-Q · filed 2024-08-07 | |
| 2024-03-31 | $1.54M 10-K · filed 2025-06-27 | |
| 2023-12-31 | $1.93M 10-Q · filed 2024-02-14 | |
| 2023-09-30 | $2.64M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $2.64M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $2.65M 10-K · filed 2024-06-24 | |
| 2022-12-31 | $3.75M 10-Q · filed 2023-02-14 | |
| 2022-09-30 | $3.75M 10-Q · filed 2022-11-01 | |
| 2022-06-30 | $3.62M 10-Q · filed 2022-08-05 | |
| 2022-03-31 | $3.55M 10-K · filed 2023-07-07 | |
| 2021-12-31 | $5.43M 10-Q · filed 2022-02-10 | |
| 2021-09-30 | $5.50M 10-Q · filed 2021-10-29 | |
| 2021-06-30 | $5.48M 10-Q · filed 2021-08-11 | |
| 2021-03-31 | $5.48M 10-K · filed 2022-06-23 | |
| 2020-12-31 | $5.16M 10-Q · filed 2021-02-16 | |
| 2020-09-30 | $6.68M 10-Q · filed 2020-11-20 | |
| 2020-06-30 | $6.52M 10-Q · filed 2020-08-19 | |
| 2020-03-31 | $4.25M 10-K · filed 2021-06-14 | |
| 2019-12-31 | $3.58M 10-Q · filed 2020-02-10 | |
| 2019-09-30 | $3.11M 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $1.97M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $248.00K 10-K · filed 2020-07-13 | |
| 2018-12-31 | $0.00 10-Q · filed 2019-02-12 | |
| 2018-09-30 | $650.00K 10-Q · filed 2018-10-16 | |
| 2018-06-30 | $649.60K 10-Q · filed 2018-08-03 | |
| 2018-03-31 | $486.00K 10-K · filed 2019-06-14 | $486.50K 10-K · filed 2018-06-21 |
| 2017-03-31 | $0.00 10-K · filed 2018-06-21 | |
| 2016-09-30 | $58.65K 10-Q · filed 2016-11-21 | |
| 2016-06-30 | $58.65K 10-Q · filed 2016-08-16 | |
| 2016-03-31 | $162.09K 10-K · filed 2017-07-14 | |
| 2015-12-31 | $651.15K 10-Q · filed 2016-02-16 | |
| 2015-09-30 | $390.26K 10-Q · filed 2015-11-13 | |
| 2015-06-30 | $1.27M 10-Q · filed 2015-08-14 | |
| 2015-03-31 | $709.65K 10-K · filed 2016-07-14 | |
| 2014-12-31 | $768.83K 10-Q · filed 2015-02-12 | |
| 2014-09-30 | $749.82K 10-Q · filed 2014-11-13 | |
| 2014-06-30 | $758.39K 10-Q · filed 2014-08-14 | |
| 2014-03-31 | $611.70K 10-K · filed 2015-07-14 | |
| 2013-12-31 | $687.88K 10-Q · filed 2014-02-14 | |
| 2013-09-30 | $503.03K 10-Q · filed 2013-11-08 | |
| 2013-06-30 | $411.93K 10-Q · filed 2013-08-16 | |
| 2013-03-31 | $407.06K 10-K · filed 2014-07-15 | |
| 2012-12-31 | $482.66K 10-Q · filed 2013-02-13 | |
| 2012-09-30 | $429.35K 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $429.71K 10-Q/A · filed 2012-08-21 | |
| 2012-03-31 | $387.48K 10-K · filed 2014-07-15 | |
| 2011-12-31 | $767.43K 10-Q · filed 2012-02-16 | |
| 2011-09-30 | $103.73K 10-Q · filed 2011-11-18 | |
| 2011-06-30 | $182.57K 10-Q · filed 2011-08-18 | |
| 2011-03-31 | $133.54K 10-K · filed 2012-07-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |